Table 2.
Factor Comparison | Aggrecan | Collagen Type II | Collagen Type I |
---|---|---|---|
−TGF-β1 vs. +TGF-β1 | p < 0.05 | p < 0.05 | p < 0.05 |
PCL vs. PCL/ECM | NS | NS | p < 0.05 |
Day 0 vs. Day 9 | p < 0.05 | NS | p < 0.05 |
Day 0 vs. Day 15 | p < 0.05 | p < 0.05 | p < 0.05 |
Day 0 vs. Day 21 | p < 0.05 | p < 0.05 | p < 0.05 |
Day 9 vs. Day 15 | NS | p < 0.05 | p < 0.05 |
Day 9 vs. Day 21 | p < 0.05 | p < 0.05 | p < 0.05 |
Day 15 vs. Day 21 | p < 0.05 | p < 0.05 | NS |
Significance levels were determined using a three-factor ANOVA and the Tukey procedure. Not significant is abbreviated as NS.